AI MARKET SCANNING

aTyr Pharma, Inc.

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +0.04%
MAX GAP RECORD -8.27%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ATYR
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 10, 2026 Earnings Release 2026-08-10 (BEFORE OPEN)
+4.70%
May 15, 2026 Earnings Release 2026-05-15 (BEFORE OPEN)
+3.57%
Mar 05, 2026 Earnings Release 2026-03-05 (AFTER CLOSE)
-2.99%
Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE)
-2.60%
Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE)
+0.00%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
-1.58%
Mar 13, 2025 Earnings Release 2025-03-13 (AFTER CLOSE)
-8.27%
Nov 07, 2024 Earnings Release 2024-11-07 (AFTER CLOSE)
-1.61%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.1%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ATYR

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗